New Products

ROCHESTER, N.Y. — VoicePort, LLC announced today the launch of its Medication Synchronization automated solution with two U. S. pharmacy chain clients and are in final stage negotiations with several others in support of helping pharmacies deliver increased patient health-and-wellness.

SAN FRANCISCO — Anti-aging skin care brand Algenist has announced that its new product, Advanced Anti-Aging Repairing Oil, is now available internationally on store shelves at Sephora.

According to the company, the anti-aging serum is the first commercial product to feature Solazyme’s Microalgae Oil. The patent-pending advanced Microalgae Oil was developed by Solazyme, a renewable oil and bioproducts company. In addition to Sephora and Sephora inside jcpenney, the new product can be found at Space NK, QVC, Sephora.com and Algenist.com.

ATLANTA — Healthy Hair Journey Enterprises has introduced the Hydratherma Naturals Healthy Hair Care Collection, a line of natural-based products developed to improve, enhance and maintain healthy hair.

DSN estimates that annualized sales of cold and allergy products through mid-June were up 7.9%, representing almost $570 million in incremental dollars.

What are the chances of that happening again?

HENDERSONVILLE, N.C. — GutZgray is encouraging consumers to embrace their graying locks with its new line of hair care products designed to invigorate gray hair.

Positioned as the first hair care line especially formulated for the texture of gray and colored gray hair, GutZgray is a unisex hair care line that utilizes the latest technology in non-embryonic stem cell research to enhance the look and feel of gray hair. Gray hair tends to be coarser than hair that retains natural color, and the line focuses on the texture — not color — of gray hair.

NEW YORK — Keryx Biopharmaceuticals, Inc., today announced the submission of a new drug application to the U.S. Food and Drug Administration seeking approval for the marketing and sale of Zerenex (ferric citrate coordination complex), the company's drug candidate for the treatment of elevated serum phosphorus levels, or hyperphosphatemia, in patients with chronic kidney disease on dialysis.

FORT WASHINGTON, Pa. — There's a lot of talk this year about the return of some venerable brand names in the OTC aisles, particularly Tylenol. But if the soft launch of McNeil Consumer's Children's Tylenol serves as any kind of barometer, the return of the brands will be a big deal. Without the expected marketing hype this fourth quarter, annualized sales of Children's Tylenol were up 31.8% to $51.4 million, securely resuming its claim as the best-selling children's fever reducer for the 52 weeks ended June 16 across total U.S. multi-outlets, according to IRI.

The big news in incontinence is Oxytrol, which doesn't reach store shelves until September. It's a switched product coming from Merck Consumer Care that brings an entirely new indication to the over-the-counter space — overactive bladder in women.

Some analysts are hesitant to suggest a new OTC category will translate into blockbuster-style sales. However, overactive bladder is a lot like smoking cessation or weight loss in the sense that women don't necessarily discuss these symptoms with their doctors, according to the National Association for Continence.